672285-91-5 Usage
General Description
1-Piperazineaceticacid, 4-ethyl-(9CI) is a chemical compound with the molecular formula C8H16N2O2. It is also known by its chemical name ethyl piperazine-1-carboxylate. 1-Piperazineaceticacid,4-ethyl-(9CI) is a derivative of piperazine, which is a heterocyclic amine. It is widely used in the pharmaceutical industry as a building block for the synthesis of various biologically active compounds. It has also been studied for its potential use as an anticonvulsant and anxiolytic agent. Additionally, it has been investigated for its potential to act as an analgesic and anti-inflammatory agent. Overall, 1-Piperazineaceticacid, 4-ethyl-(9CI) is an important chemical compound with various potential pharmaceutical applications.
Check Digit Verification of cas no
The CAS Registry Mumber 672285-91-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,7,2,2,8 and 5 respectively; the second part has 2 digits, 9 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 672285-91:
(8*6)+(7*7)+(6*2)+(5*2)+(4*8)+(3*5)+(2*9)+(1*1)=185
185 % 10 = 5
So 672285-91-5 is a valid CAS Registry Number.
InChI:InChI=1/C8H16N2O2/c1-2-9-3-5-10(6-4-9)7-8(11)12/h2-7H2,1H3,(H,11,12)
672285-91-5Relevant articles and documents
PROTEIN KINASE INHIBITORS
-
, (2015/02/18)
A compound of formula (I), wherein R3, R4, G, B, M, and Z are as defined in the claims, and pharmaceutically acceptable salts thereof are disclosed. The compounds of formula (I) possess utility as FGFR inhibitors and are useful in the treatment of a condition, where FGFR kinase inhibition is desired, such as cancer.
3-BENZOFURANYL-INDOL-2-ONE DERIVATIVES SUBSTITUTED AT THE 3 POSITION, PREPARATION THEREOF, AND THERAPEUTIC USE THEREOF
-
, (2012/03/08)
The invention relates to 3-benzofuranyl-indol-2-one derivatives substituted at the 3 position and of the formula (I) where R1, R2, R3, R4, R5 and n are such as defined in claim 1, to a method for preparing same, and to the therapeutic use of said compound
NK1 and NK3 antagonists
-
Page/Page column 28, (2010/02/14)
The invention is to a compound exhibiting neurokinin inhibitory properties, a pharmaceutical composition comprising same and a method of treatment for neurokinin-mediated conditions.
